Altimmune (ALT) Cash from Investing Activities (2010 - 2026)
Altimmune (ALT) reported Cash from Investing Activities of -$3.7 million for Q1 2026, up 27.66% year-over-year from -$2.9 million in Q1 2025, and up 95.34% on a QoQ basis from -$79.2 million in Q4 2025.
Altimmune (ALT) has 17 years of Cash from Investing Activities data on file, last reported at -$3.7 million in Q1 2026.
- Quarterly Cash from Investing Activities rose 27.66% year-over-year to -$3.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$131.1 million (down 2272.06% YoY) and the FY2025 annual result came in at -$132.5 million, down 366.68% from the prior year.
- Cash from Investing Activities climbed to -$3.7 million in Q1 2026 per ALT's latest filing, from -$79.2 million in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $101.1 million in Q2 2025 and bottomed at -$149.3 million in Q3 2025.
- The 5-year median for Cash from Investing Activities is -$3.7 million (2026), against an average of -$13.2 million.
- The widest annual swing landed in 2023, when Cash from Investing Activities jumped 147900.0%; it then tumbled 12553.79% in 2025.
- Tracing ALT's Cash from Investing Activities over 5 years: stood at $981000.0 in 2022, then sank by 911.31% to -$8.0 million in 2023, then surged by 271.28% to $13.6 million in 2024, then plunged by 680.68% to -$79.2 million in 2025, then jumped by 95.34% to -$3.7 million in 2026.
- Per Business Quant, the three latest ALT Cash from Investing Activities figures stand at -$3.7 million (Q1 2026), -$79.2 million (Q4 2025), and -$149.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -2.89 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 638.50 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -431.90 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -428.90 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | -25.54 Mn |
| 10 | Altimmune | 379.61 Mn | 379.61 Mn | - | -3.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.69 Mn |
| Mar 31, 2026 | -3.69 Mn |
| Dec 31, 2025 | -79.16 Mn |
| Dec 31, 2025 | -79.16 Mn |
| Sep 30, 2025 | -149.32 Mn |
| Sep 30, 2025 | -149.32 Mn |
| Jun 30, 2025 | 101.11 Mn |
| Jun 30, 2025 | 101.11 Mn |
| Mar 31, 2025 | -5.10 Mn |
| Mar 31, 2025 | -5.10 Mn |
| Dec 31, 2024 | 13.63 Mn |
| Dec 31, 2024 | 13.63 Mn |
| Sep 30, 2024 | 1.20 Mn |
| Sep 30, 2024 | 1.20 Mn |
| Jun 30, 2024 | -3.70 Mn |
| Jun 30, 2024 | -3.70 Mn |
| Mar 31, 2024 | -39.52 Mn |
| Mar 31, 2024 | -39.52 Mn |
| Dec 31, 2023 | -7.96 Mn |
| Dec 31, 2023 | -7.96 Mn |
| Sep 30, 2023 | 4.40 Mn |
| Sep 30, 2023 | 4.40 Mn |
| Jun 30, 2023 | 3.99 Mn |
| Jun 30, 2023 | 3.99 Mn |
| Mar 31, 2023 | 13.30 Mn |
| Mar 31, 2023 | 13.30 Mn |
| Dec 31, 2022 | 981,000.00 |
| Dec 31, 2022 | 981,000.00 |
| Sep 30, 2022 | -25.40 Mn |
| Sep 30, 2022 | -25.40 Mn |
| Jun 30, 2022 | -48.97 Mn |
| Jun 30, 2022 | -48.97 Mn |
| Mar 31, 2022 | -9,000.00 |
| Mar 31, 2022 | -9,000.00 |
| Dec 31, 2021 | 24.87 Mn |
| Dec 31, 2021 | 24.87 Mn |
| Sep 30, 2021 | 18.41 Mn |
| Sep 30, 2021 | 18.41 Mn |
| Jun 30, 2021 | 25.08 Mn |
| Jun 30, 2021 | 25.08 Mn |
| Mar 31, 2021 | 19.17 Mn |
| Mar 31, 2021 | 19.17 Mn |
| Dec 31, 2020 | -37.00 Mn |
| Dec 31, 2020 | -37.00 Mn |
| Sep 30, 2020 | -47.89 Mn |
| Sep 30, 2020 | -47.89 Mn |
| Jun 30, 2020 | 6.10 Mn |
| Jun 30, 2020 | 6.10 Mn |
| Mar 31, 2020 | 6.56 Mn |
| Mar 31, 2020 | 6.56 Mn |
| Dec 31, 2019 | -52,682.00 |
| Dec 31, 2019 | -52,682.00 |
| Sep 30, 2019 | -28.22 Mn |
| Sep 30, 2019 | -28.22 Mn |
| Jun 30, 2019 | -12,854.00 |
| Jun 30, 2019 | -12,854.00 |
| Mar 31, 2019 | -4,246.00 |
| Mar 31, 2019 | -4,246.00 |
| Dec 31, 2018 | -8,135.00 |
| Dec 31, 2018 | -8,135.00 |
| Sep 30, 2018 | -153,856.00 |
| Sep 30, 2018 | -153,856.00 |
| Jun 30, 2018 | -171,688.00 |
| Jun 30, 2018 | -171,688.00 |
| Mar 31, 2018 | -667,463.00 |
| Mar 31, 2018 | -667,463.00 |
| Dec 31, 2017 | -28,740.00 |
| Dec 31, 2017 | -28,740.00 |
| Sep 30, 2017 | -15,428.00 |
| Sep 30, 2017 | -15,428.00 |
| Jun 30, 2017 | 13.63 Mn |
| Jun 30, 2017 | 13.63 Mn |
| Mar 31, 2017 | 143,123.00 |
| Mar 31, 2017 | 143,123.00 |
| Dec 31, 2016 | -41,223.00 |
| Dec 31, 2016 | -41,223.00 |
| Sep 30, 2016 | -119,449.00 |
| Sep 30, 2016 | -119,449.00 |
| Jun 30, 2016 | -59,748.00 |
| Jun 30, 2016 | -59,748.00 |
| Mar 31, 2016 | -150.00 |
| Mar 31, 2016 | -150.00 |
| Dec 31, 2015 | -18,230.00 |
| Dec 31, 2015 | -18,230.00 |
| Sep 30, 2015 | -12,000.00 |
| Sep 30, 2015 | -12,000.00 |
| Jun 30, 2015 | -20,925.00 |
| Jun 30, 2015 | -20,925.00 |
| Mar 31, 2015 | -27,752.00 |
| Mar 31, 2015 | -27,752.00 |
| Sep 30, 2014 | -13,042.00 |
| Sep 30, 2014 | -13,042.00 |
| Jun 30, 2014 | -42,177.00 |
| Jun 30, 2014 | -42,177.00 |
| Mar 31, 2014 | -29,050.00 |
| Mar 31, 2014 | -29,050.00 |
| Sep 30, 2013 | -10,498.00 |
| Sep 30, 2013 | -10,498.00 |
| Jun 30, 2013 | -45,113.00 |
| Jun 30, 2013 | -45,113.00 |
| Mar 31, 2013 | -25,468.00 |
| Mar 31, 2013 | -25,468.00 |
| Mar 31, 2012 | 67,400.00 |
| Mar 31, 2012 | 67,400.00 |
| Dec 31, 2011 | 1.76 Mn |
| Dec 31, 2011 | 1.76 Mn |
| Sep 30, 2011 | -41,075.00 |
| Sep 30, 2011 | -41,075.00 |
| Dec 31, 2010 | -50,002.00 |
| Dec 31, 2010 | -50,002.00 |
| Sep 30, 2010 | 10,835.00 |
| Sep 30, 2010 | 10,835.00 |